AtheroNova Meets with FDA; Takes on Leading Killer: Heart Disease (OTC:AHRO) – Small Cap Network

Ofloxacin, Azelex, Avage (Retinoid), Latisse and Viscoelastic intraocular. In an 8-K filed Oct 28 AHRO had an Unregistered Sale of Equity Securities in which it sold “Thirty Accredited Investors” an aggregate of 1,717,227 units at $0.55 per unit …

Leave a Reply

Your email address will not be published.

*